Skip to main content
Top
Published in: Supportive Care in Cancer 1/2020

01-01-2020 | Affective Disorder | Original Article

Music, heart rate variability, and symptom clusters: a comparative study

Authors: Shu-Chuan Chen, Ming-Lee Yeh, Hsiu-Ju Chang, Mei-Feng Lin

Published in: Supportive Care in Cancer | Issue 1/2020

Login to get access

Abstract

Purpose

This study aimed to explore the possible range of change of a single-session music intervention (SMI) on symptom clusters and neurological reactivity for women with breast cancer undergoing chemotherapy.

Methods

A parallel and randomized, controlled study with repeated measures design was used. A total of 100 women with breast cancer were randomly assigned to the SMI or a control group. The outcome measurements of symptom cluster were collected using the Multidimensional Fatigue Symptom Inventory, Pittsburgh Sleep Quality Index, the Hospital Anxiety and Depression Scale, and the neurological reactivity with heart rate variability at four time points: before commencement of the intervention (T0), immediately afterward (T1), 1 week later (T2), and 3 weeks after the intervention (T3).

Results

Of the 50 women in each group, 46 in the SMI and 48 in the control group completed the post-test at T3. Multivariate analysis of variance indicated that the SMI group had a medium effect in change of symptom clusters compared to the control group at T2. Moreover, after adjusting for baseline between normal and higher levels of sympathetic tone activity, significant differences existed in fatigue and depression at T2 and sleep disturbance at T3.

Conclusions

A single-session music intervention can be effectively used to reduce symptom clusters for women with breast cancer. Targeting those who have a higher level of sympathetic tone activity is recommended.
Literature
5.
go back to reference Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed
7.
go back to reference Donovan KA, Jacobsen PB (2007) Fatigue, depression, and insomnia: evidence for a symptom cluster in cancer. Semin Oncol Nurs 23(2):127–135CrossRefPubMed Donovan KA, Jacobsen PB (2007) Fatigue, depression, and insomnia: evidence for a symptom cluster in cancer. Semin Oncol Nurs 23(2):127–135CrossRefPubMed
20.
go back to reference Vanderlei LCM, Pastre CM, Hoshi RA, de Carvalho TD, de Godoy MF (2009) Basic notions of heart rate variability and its clinical applicability. Rev Bras Cir Cardiovasc 24(2):205–217CrossRefPubMed Vanderlei LCM, Pastre CM, Hoshi RA, de Carvalho TD, de Godoy MF (2009) Basic notions of heart rate variability and its clinical applicability. Rev Bras Cir Cardiovasc 24(2):205–217CrossRefPubMed
33.
go back to reference Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed
35.
go back to reference Bagri DR, Gupta A, Dube A, Gupta R (2016) Assessment of examination stress and HRV in adolescents. Natl J Integr Res Med 7(4):1–7 Bagri DR, Gupta A, Dube A, Gupta R (2016) Assessment of examination stress and HRV in adolescents. Natl J Integr Res Med 7(4):1–7
42.
go back to reference Lafçi D, Öztunç G (2015) The effect of music on the sleep quality of breast cancer patients. Int J Caring Sci 8(3):633–640 Lafçi D, Öztunç G (2015) The effect of music on the sleep quality of breast cancer patients. Int J Caring Sci 8(3):633–640
Metadata
Title
Music, heart rate variability, and symptom clusters: a comparative study
Authors
Shu-Chuan Chen
Ming-Lee Yeh
Hsiu-Ju Chang
Mei-Feng Lin
Publication date
01-01-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04817-x

Other articles of this Issue 1/2020

Supportive Care in Cancer 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine